scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicMisleading ads

Topic: misleading ads

Patanjali chyawanprash ad row: Disparaging rival’s product completely impermissible, says Delhi HC

In its advertisement, Patanjali had cautioned consumers against buying chyawanprash which possess 41 Ayurvedic herbs—a fact highlighted by Dabur while promoting its product.

Digital space hosts lion’s share of misleading healthcare ads, majority on sexual wellness

Healthcare sector accounted for a maximum 19% or 1,569 of 8,229 advertisements scrutinised by ASCI during 2023-24. Nearly 86% of drugs found illegal were on digital platforms.

BJP files complaint to ECI for ‘malicious, false, unverified & defamatory’ ads by Congress

In a letter to Election Commission of India, BJP says Congress published ads, just 2 days before polls, with the heading 'Chambu' to portray that Centre has cheated state of Karnataka.

‘What about you?’ At Patanjali hearing, Supreme Court raps IMA for docs ‘advocating’ costly drugs

Top court asserts consumers had a right to know whether they were being misled by FMCG companies too and what agencies were doing to prevent such misuse.

SC praises Ramdev for Yoga work but refuses to let him off in contempt case — ‘not so innocent’

Yoga guru offers to publish a public apology for misleading ads by Divya Pharmacy, saying it 'happened on impulse' and that he would be careful in future.

SC declines apology affidavits of Ramdev, Balakrishnan in Patanjali misleading ads case

In two separate affidavits filed, Ramdev and Balkrishna have tendered an unqualified apology for the 'breach of the statement' recorded in 21 November, 2023 order of the apex court.

Don’t let just Ramdev’s Patanjali take the fall. Allopathy isn’t immune to ‘misleading’ ads

The Indian Medical Association and other allopathic doctors have no moral basis to cast aspersions on Ayurveda or AYUSH companies.

Recommended Patanjali’s Coronil as supporting medicine for COVID, Centre tells SC amid ad row

In an affidavit before the SC, the Union Ayush ministry said it had issued repeated warnings to Patanjali. But it also slams petitioner IMA for ‘denigrating a system of medicine’.   

Patanjali MD Balkrishna apologises to SC over ‘misleading ads’, day after Baba Ramdev is summoned

Acharya Balkrishna says company regrets putting out the publicity campaign that questioned efficacy of modern medicine, but also termed the Drugs & Magic Remedies Act as 'archaic'.

Patanjali misleading ads: SC orders Baba Ramdev, Acharya Balkrishna to be present at next hearing

Indian Medical Association has accused Patanjali of carrying out a smear campaign on evidence-based medicine. Court noted that no response filed by Patanjali on its contempt notice.

On Camera

How Gen-Z is changing the violent extremist landscape online

The evolving extremist threat now hinges on young people online, demanding new strategies beyond traditional counter-terror models.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.